Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
  1. 4 Open-market sale President and CEO sold 1,500 shares at $9.52 ($14,280)
  2. 4 Open-market sale President and CEO sold 3,000 shares at an average $9.61 ($28,815)
  3. 4 Open-market sale President and CEO sold 3,000 shares at an average $9.50 ($28,485)
  4. 4 Exercise or conversion Chief Scientific Officer acquired 25,000 shares (option exercise)
  5. 4 Open-market sale President and CEO sold 7,500 shares at $11.60 ($87,000)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale President and CEO sold 7,500 shares at $10.25 ($76,844)
  9. 4 Open-market buy Senior VP, GC and Secretary bought 10,000 shares at an average $9.48 ($94,793)
  10. 4 Open-market sale President and CEO sold 7,500 shares at $9.54 ($71,582)
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 12 of 14 · 278 filings